Furthermore, the immunohistochemistry results showed that niclosamide treatment markedly decreased the CDC34 and MCM2 positive-stained tumor cells compared to control group (Figure 5D), which indicated that niclosamide blocked the initiation of DNA synthesis in S phase. Here, MCM2 is linked to neoplasm.